Managing the Cost of Specialty Drug Spending

Managing the Cost of Specialty Drug Spending

One of the largest components of a self-funded employer’s health care costs is specialty drugs.   The cost of specialty drugs has grown at a pace of up to 20% annually and may reach 40% of the total pharmacy drug spending   in the next five years.   Specialty drugs are those which require special handling and administration.   The drug classes include autoimmune, multiple sclerosis, oral oncology, growth hormone, hepatitis C and anticoagulants.

Self- insured employers are finding ways to manage the increasing cost by addressing cost factors such as reimbursement, benefit design, channel management and formulary management. For example:

  • Move delivery of provider-administered drugs from the hospital to the physician’s office to help reduce the cost while insuring continuity and quality of care for the patient.
  • Move the payment of self-administered injectables   from the medical benefit to the pharmacy benefit, where   savings can be seen. Formulary management can be used to encourage the selection of low-cost, high-quality alternatives.

A self-insured employer should be aware of these rising costs and implement a Specialty Drug Management Strategy that will help control costs while maintaining quality of care for their employees.

Source:   The Self Insurer Magazine   August 2013.


Contact Block (Blog)

Recent Comments

    Newsletter Signup

    Signup to start receiving the latest newsletters from StopLoss right to your email.
    Stay up to date on insurance trends and insights.

    Back to Top

    In 2011, the top 5 most expensive medical conditions treated in US hospitals were: Septicemia, Osteoarthritis, Complication of device, implant or graft, Liveborn, and Acute myocardial infarction

    From 2010 to 2013, the number of claims that were individually $1 million or above rose by 1,000%

    In 2017 approximately 18% of the American public will purchase insurance through exchanges, radically transforming the health insurance landscape.

    In 2014, 98% of large firms (= 200 Workers) offer 1+ wellness programs to their employees.

    The most costly 1% of patients account for 20% of national health expenditures – accruing average annual expenses of nearly $90,000 per person.

    6% of firms offering fully-insured plans report they intend to self-insure because of Obamacare.

    In 2014, PPO plans remained the most common plan type, enrolling 58% of covered workers.

    In 2012, 93% of businesses with 5,000+ employees and 80% of companies with 1,000-4,999 employees were self-funded

    Massachusetts has the third-highest prevalence of self-funded insurance in the small-group market (Fewer than 50 employees).

    In 2013, the average deductible was $2,906 for individuals selecting plans from marketplaces. This compares with average deductibles of $1,135 for an individual with employer coverage.

    In 2013, the average annual premiums for employer-sponsored health insurance are $5,884 for single coverage and $16,351 for family coverage, up 5% and 4% respectively from 2012.

    From 2010 – 2013, cancer followed by chronic/end stage renal disease and leukemia accounted for the top 3 costliest illnesses.